Evidence map›Paper›PMID 35798777›Full record

ArticleScientific reports2022

Detecting lineage-defining mutations in SARS-CoV-2 using colorimetric RT-LAMP without probes or additional primers.

Carlos Abelardo Dos Santos, Lívia do Carmo Silva, Marcio Neres de Souza Júnior, Geovana de Melo Mendes, Paulo Felipe Neves Estrela, Kézia Gomes de Oliveira, Juliana Santana de Curcio, Paola Cristina Resende, Marilda Mendonça Siqueira, Alex Pauvolid-Corrêa and 2 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Carlos Abelardo Dos SantosLaboratório de Genética Molecular e Citogenética, Departamento de Genética, Instituto de Ciências Biológicas I, Universidade Federal de Goiás, Goiânia, Goiás State, 74001-970, Brazil.
Lívia do Carmo SilvaLaboratório de Genética Molecular e Citogenética, Departamento de Genética, Instituto de Ciências Biológicas I, Universidade Federal de Goiás, Goiânia, Goiás State, 74001-970, Brazil.
Marcio Neres de Souza JúniorInstituto de Química, Universidade Federal de Goiás, Goiânia, Brazil.
Geovana de Melo MendesInstituto de Química, Universidade Federal de Goiás, Goiânia, Brazil.
Paulo Felipe Neves EstrelaInstituto de Química, Universidade Federal de Goiás, Goiânia, Brazil.
Kézia Gomes de OliveiraInstituto de Química, Universidade Federal de Goiás, Goiânia, Brazil.
Juliana Santana de CurcioLaboratório de Genética Molecular e Citogenética, Departamento de Genética, Instituto de Ciências Biológicas I, Universidade Federal de Goiás, Goiânia, Goiás State, 74001-970, Brazil.
Paola Cristina ResendeLaboratory of Respiratory Viruses and Measles, Reference Laboratory for COVID-19 (WHO) of Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
Marilda Mendonça SiqueiraLaboratory of Respiratory Viruses and Measles, Reference Laboratory for COVID-19 (WHO) of Oswaldo Cruz Foundation (Fiocruz), Rio de Janeiro, Brazil.
Alex Pauvolid-CorrêaDepartment of Veterinary Integrative Biosciences, Texas A&M University, College Station, TX, USA.
Gabriela Rodrigues Mendes DuarteInstituto de Química, Universidade Federal de Goiás, Goiânia, Brazil.
Elisângela de Paula Silveira-LacerdaLaboratório de Genética Molecular e Citogenética, Departamento de Genética, Instituto de Ciências Biológicas I, Universidade Federal de Goiás, Goiânia, Goiás State, 74001-970, Brazil. elacerda@ufg.br.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the advance of vaccination worldwide, epidemic waves caused by more transmissible and immune evasive genetic variants of SARS-CoV-2 have sustained the ongoing pandemic of COVID-19. Monitoring such variants is expensive, as it usually relies on whole-genome sequencing methods. Therefore, it is necessary to develop alternatives that could help identify samples from specific variants. Reverse transcription loop-mediated isothermal amplification is a method that has been increasingly used for nucleic acid amplification, as it is cheaper and easier to perform when compared to other molecular techniques. As a proof of concept that can help distinguish variants, we present an RT-LAMP assay capable of detecting samples carrying a group of mutations that can be related to specific SARS-CoV-2 lineages, here demonstrated for the Variant of Concern Gamma. We tested 60 SARS-CoV-2 RNA samples extracted from swab samples and the reaction showed a sensitivity of 93.33%, a specificity of 88.89% and a kappa value of 0.822 for samples with a Ct ≤ 22.93. The RT-LAMP assay demonstrated to be useful to distinguish VOC Gamma and may be of particular interest as a screening approach for variants in countries with poor sequencing coverage.

Indexed as

COVID-19SARS-CoV-2ColorimetryDNA PrimersHumansMolecular Diagnostic TechniquesMutationNucleic Acid Amplification TechniquesRNA, ViralSensitivity and SpecificityDNA PrimersRNA, Viral

Identifiers

PMID35798777
PMCPMC9261132

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.